Investors

Join the breakthrough in surgical wound closure. AnCor®: 9x stronger adhesion, patented, validated, already commercialised.

€1.4M public funding raised 20+ international patents 6 published studies France 2030 Laureate

Investment Opportunity

COHESIVES Medical is a deep-tech MedTech startup in growth phase. Following €1.4M in public grants, a first product commercialised and an exclusive OTC license signed, the company is preparing its next funding round to accelerate clinical and regulatory development.

Key Metrics

20 international patents
6 published scientific studies
1 veterinary product commercialised (Novacika®)
1 OTC device — CE/FDA clearance in progress
4 indications in active development

Stage & Fundraising Target

Details of our funding round (stage, target amount, valuation) will be shared soon.
Contact us to learn more

Use of Funds

Detailed fund allocation breakdown (clinical studies, regulatory, team, operations) will be available soon.
Contact us to learn more

Why Invest in COHESIVES

Protected Technology

20 international patents. AnCor® anchors in wet biological tissue with 9x stronger adhesion. Technology platform covering 4 surgical and cutaneous indications.

Discover the technology

Scientific & Institutional Validation

6 published studies. France 2030 laureate, DGA-RAPID, BPI i-Nov. 3 partner public laboratories (IS2M, LVTS, LBTI). CE Mark in progress.

View the evidence

Commercial Traction

1 veterinary product commercialised (Novacika®). Exclusive OTC license signed with a major international player. US launch 2026, Europe/Asia 2028.

View the platform

Key Figures

20 patents filed worldwide

1.4 M€ raised public funding

196 beta tests performed in real-world conditions

1 OTC device exclusive license — US launch 2026

Funded by

Certifications

CE Mark (in progress)

ISO 13485

Awards & Recognition

Member of

Bertrand Perrin

Founder & CEO MD, PhD — Cardiac Surgeon

Cardiac surgeon and PhD, Bertrand Perrin founded COHESIVES in 2014 after clinically identifying the need for a surgical adhesive capable of anchoring in wet biological tissue. He drives the scientific vision and strategic development of AnCor® technology.

Patrick Goudot

Marketing Director PharmD, MBA

Stéphanie Carre

R&D & Manufacturing Director

Pauline Châlons

Projects & Pre-clinical Director

Detailed Track Records

Full leadership team track records will be available soon.

Scientific Advisory Board

The Scientific Advisory Board composition will be shared soon.

Meet the full team →

Investor Presentation

Our investor presentation (PDF) will be available for download soon.
Contact us to receive our materials

Request Data Room

Want to go deeper? Request access to our detailed documentation through our contact form.

Contact the Founder

Want to speak directly with Dr Bertrand Perrin, founder and CEO of COHESIVES Medical?

Direct Contact

The founder's direct contact details will be displayed here soon. In the meantime, use our contact form and select "Investor".

Contact form